Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 687 participants.

Also called NCT04237493

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 687 participants (enrolled count) (from the registry)
Sponsor
University of Jordan (from the registry)
Registry
  • NCT NCT04237493
Other papers using this trial's data
  • Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial Frontiers in endocrinology, 2021 DOI, PubMed 34305809, PMC8294055 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Jordan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04237493. Randomized; no masking; primary purpose treatment. Start 2017-02-14 (actual); primary completion 2017-07-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Metformin and Glimepiride (Low Dosage)
Intervention (Drug)
Metformin and Vildagliptin (Low Dosage)
Intervention (Drug)
Metformin and Insulin Glargine U100 (Low Dosage)
Intervention (Drug)
Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage)
Intervention (Drug)
Metformin and Glimepiride (Regular Dosage)
Intervention (Drug)
Metformin and Vildagliptin (Regular Dosage)
Intervention (Drug)
Metformin and Insulin Glargine U100 (Regular Dosage)
Intervention (Drug)
Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage)
Lead sponsor
University of Jordan (class: other)

Record details

Record id
cardio:ct-nct04237493
Content hash
e866e1bf3e2729bc40b3962e2bcb4149a43885dbdcd88bdb095e550a3a4d40b7